US FDA Holds First Hybrid Meeting With Industry
Executive Summary
A Type A meeting was held in-person with a virtual contingent, the FDA clarified to the Pink Sheet. Several other meeting requests received were eligible, but did not seek an in-person session.
You may also be interested in...
Minutes Matter: Why The US FDA Refuses To Record Formal Meetings
Given confusion sometimes emerges about the content of formal meeting minutes, recording the meetings would seem like an easy solution, but also could muddy the administrative record.
Minutes Matter: Why The US FDA Refuses To Record Formal Meetings
Given confusion sometimes emerges about the content of formal meeting minutes, recording the meetings would seem like an easy solution, but also could muddy the administrative record.
Sponsors Still Not Racing To Schedule In-Person Meetings With US FDA
The vast majority of meeting requests eligible for the in-person/virtual format were not requested as such, according to Center for Drug Evaluation and Research data.